Johnson & Johnson will report its Q3 2017 earnings on October 17, and we expect the company to post solid numbers, owing to three primary factors – a ramp up in key oncology drug sales, the Actelion acquisition, and forex gains.
from Forbes Real Time https://www.forbes.com/sites/greatspeculations/2017/10/13/what-factors-will-drive-johnson-johnsons-q3-earnings/
via IFTTT
No comments:
Post a Comment